Aptevo Therapeutics (APVO) vs 60 Degrees Pharmaceuticals (SXTP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
60 Degrees Pharmaceuticals is the larger company by market cap ($3.4 million vs $3.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APVO | SXTP |
|---|---|---|
| Share price | $1.80 | $0.9725 |
| Market cap | $3.26M | $3.42M |
| 1-day change | -2.17% | -11.59% |
| P/E ratio (TTM) | 0.03 | — |
| EPS (TTM) | $66.96 | $-5.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $31.14 | $8.62 |
| 52-week low | $1.37 | $0.84 |
| Distance from 52-week high | -94.22% | -88.72% |
| Analyst consensus | none | none |
| Avg. price target upside | +1316.67% | +280.46% |
| Average volume | 91.51K | 130.52K |
| Shares outstanding | 1.81M | 3.52M |
| Employees | 33 | 3 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aptevo Therapeutics
APVO stock →Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.
Healthcare · Biotechnology · 33 employees
About 60 Degrees Pharmaceuticals
SXTP stock →60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment.
Healthcare · Biotechnology · 3 employees
APVO vs SXTP FAQ
Which is bigger, Aptevo Therapeutics or 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals (SXTP) is larger, with a market capitalization of $3.42M compared with $3.26M for Aptevo Therapeutics (APVO).
Are Aptevo Therapeutics and 60 Degrees Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.